AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03207243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK3772847
Description: GSK3772847 10 mg/kg will be administered as IV infusion once every 4 weeks to randomized subjects.
Study NCT03207243 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo sterile normal saline will be administered as IV infusion once every 4 weeks to randomized subjects.
Study NCT03207243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol
Description: FP/Sal 500/50 mcg will be administered via inhalation route twice daily to all subjects.
Study NCT03207243 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Fluticasone propionate/salmeterol
Description: FP/Sal 500/50 mcg will be administered via inhalation route twice daily to all subjects.
Study NCT03207243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Description: FP 500, 250, 100 or 50 mcg will be administered via inhalation route twice daily to all subjects.
Study NCT03207243 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Fluticasone propionate
Description: FP 500, 250, 100 or 50 mcg will be administered via inhalation route twice daily to all subjects.
Study NCT05823324 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapeutic play group
Description: The dramatization method with teddy bear, one of the TP methods, was applied during the PIVC intervention
Study NCT01747707 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S-1
Study NCT04228913 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Root Canal Obturation Technique
Description: This study aims to compare the effects of three different obturation techniques(cold lateral condensation,thermoplasticized solid-core carrier method, cold free flow compaction technique) on postoperative pain following the endodontic therapy
Study NCT03587324 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Whole blood aggregometry before and after vascular treatment (ASA/ Clopidogrel).
Description: To identify possible risk factors demographic data, concomitant medication, laboratory parameters, co-morbidities, severity of the condition and the type of procedure performed are documented.~Other Name: ASA (aspirin), Clopidogrel (Plavix)
Study NCT03906552 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: nonpharmalogocial methods
Description: neonates received acupressure (acupressure group) or massage (massage group) before heel lancing procedure
Study NCT03909269 — intervention group
Intervention type: DEVICE
Intervention: Continuous glucose monitoring
Description: Continuous glucose monitoring five times over 17 weeks
Study NCT03909269 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Glycaemic markers
Description: Measurement of HbA1c by immunoassay (Roche) and chromatography (TOSOH), including glycated albumin and fructosamine.
Study NCT03909269 — intervention group
Intervention type: RADIATION
Intervention: Erythrocyte life span
Description: Erythrocyte life span measured by Crom-51 labelling over 4 weeks
Study NCT03909269 — intervention group
Intervention type: DEVICE
Intervention: Carbon monoxide (CO)-rebreathing method
Description: Measurement of total blood volume, plasma volume and erythrocyte volume
Study NCT03452254 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active Bihemispheric Transcranial direct current Stimulation
Description: The session will start with the application of the with a couple of surface sponge electrodes (25-35 cm2) on the scalp. The treatment modality will be as follows:~Active tDCS: The anodic electrode will be put on affected M1. The cathodic electrode will be put on contralateral M1. We will apply a constant current of 2mA of intensity during 20 minutes while the patient performs the occupational therapy session.
Study NCT03452254 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Bihemispheric Transcranial direct current Stimulation
Description: The session will start with the application of the with a couple of surface sponge electrodes (25-35 cm2) on the scalp. The treatment modality will be as follows:~Sham tDCS: We will use the same place and parameters of stimulation applied for the active group, but the stimulator will deactivate after 30 seconds of stimulation. This will ensure that the patient will feel the initial tingling sensation at the beginning of the tDCS which is a requisite for blinding. The occupational therapy session will last one hour.
Study NCT03452254 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Modified Constraint Induced Movement Therapy
Description: Both groups will perform the mCIMT during a period of seven consecutive days. This protocol consists of two elements:~1. Restriction of the movements of the non-affected hand by wearing a mitt during six hours a day: we will use a mitt that limits the movement of the fingers but allows the free movements of the wrist, elbow, and shoulder.~2. Intensive and individualized training of the affected arm during 2 hours a day guided by an occupational therapist: the two hours training will be divided into two sessions of one hour each. Sessions will be organized in three blocks: preparation, activation, and function. In the third block, devoted to function, the patient has to choose one activity of daily living that he wants to improve.
Study NCT03452254 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Modified Constraint Induced Movement Therapy
Description: Both groups will perform the mCIMT during a period of seven consecutive days. This protocol consists of two elements:~1. Restriction of the movements of the non-affected hand by wearing a mitt during six hours a day: we will use a mitt that limits the movement of the fingers but allows the free movements of the wrist, elbow, and shoulder.~2. Intensive and individualized training of the affected arm during 2 hours a day guided by an occupational therapist: the two hours training will be divided into two sessions of one hour each. Sessions will be organized in three blocks: preparation, activation, and function. In the third block, devoted to function, the patient has to choose one activity of daily living that he wants to improve.
Study NCT02839395 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No intervention- base line
Description: the subject will sited in a dim light room. No screen light illumination.
Study NCT02839395 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acute
Description: The subject will be sited in front of computer screen light illumination for 2 hours.
Study NCT02839395 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chronic
Description: The subject will be sited in front of computer screen light illumination for 2 hours for 5 consecutive days.
Study NCT03363984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Single oral administration of 2 mg midazolam under fasted conditions/outside of meal times
Study NCT03363984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ID-082
Description: Administration of ID-082 under fasted conditions/outside of meal times
Study NCT01979276 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Romidepsin
Description: Romidepsin intravenously on days 1 and 15 of a 28-day cycle
Study NCT01979276 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pomalidomide
Description: Pomalidomide 4mg daily by mouth on days 1-21 of a 28-day cycle
Study NCT01979276 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone 40mg by mouth on days 1, 8, 15 and 22 of a 28-day cycle
Study NCT03367923 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Communication Intervention
Description: Receive email/text
Study NCT03367923 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Counseling
Description: Undergo exercise counseling
Study NCT03367923 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fitbit tracker
Description: Wear Fitbit tracker
Study NCT03367923 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT03367923 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT02136316 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral
Study NCT03367923 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telephone-Based Intervention
Description: Receive phone call
Study NCT03814382 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acupuncture needle
Description: Acupuncture needle
Study NCT02216968 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Increase vegetable intake in pre-school children
Description: 6-week Intervention: 120 AA and HA children will be shown the Puppet Shows and will be given a bag of ingredients to prepare the vegetable highlighted that week in the Puppet Show. The 6 week intervention includes a baseline assessment (1 week), followed by the intervention (4 weeks), and post assessment (1 week). The primary hypothesis to be tested is children who receive the PUPPET intervention with a parent/teacher component will demonstrate increase vegetable intake in pre-school children.
Study NCT03907176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HTX-011
Description: 300 mg
Study NCT03907176 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Luer lock applicator
Description: Applicator for instillation
Study NCT03907176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Description: 600 mg
Study NCT03907176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: 1 g
Study NCT01925118 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Irradiated donor lymphocyte infusion
Study NCT03718884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Drug Cocktail
Description: Drug cocktail consists of caffeine, warfarin plus vitamin K, omeprazole, dextromethorphan, and midazolam, administered orally
Study NCT00374127 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Marijuana blunt
Description: Blunts were fabricated by cutting the bottom third off a Dutch Master® cigar, removing all of the cigar tobacco, and replacing it with all of the marijuana contained in a NIDA marijuana cigarette (ca. 800 mg).
Study NCT00374127 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: marijuana cigarette
Description: Marijuana cigarettes were provided by the National Institute on Drug Abuse.
Study NCT02729402 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive Testing
Description: We will use a battery of neurocognitive tests to assess cognitive function before and after surgery
Study NCT01635244 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Aortic valve replacement
Description: Clinically indicated aortic valve replacement will be performed using one of three approved tissue valves (Freestyle, Magna Ease, or Trifecta).
Study NCT04451486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SB cells
Description: 1x10\*5 CD61-Lin- cells /0.25mL DPBS
Study NCT04451486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SB cells
Description: 1x10\*6 CD61-Lin- cells /0.25mL DPBS
Study NCT04451486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SB cells
Description: 1x10\*7 CD61-Lin- cells /0.25mL DPBS
Study NCT01661725 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Group ACYW135 Meningococcal Polysaccharide Vaccine
Description: 60 subjects were divided into three groups (20 subjects each group), adult (16\~30 years of age), early youth (7\~15 years of age) and children (2\~6 years of age) to receive Group ACYW135 Meningococcal Polysaccharide Vaccine, 0.5 ml, one dose regime
Study NCT01614275 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Technology-Enhanced Parent Training
Description: The training for the parents of children with autism assigned to the EIBI group will begin with completion of a structured parent-training program for 6 weeks that includes 16 to 18 sessions (three, 90-minute sessions per week). When a new topic is introduced, the initial training will include viewing a Power Point presentation, with embedded video and audio, that explains, in laymen's terms, the basic principles and processes related to the topic. The second part of the training involves a parent recruiting an adult friend, who will play the role of a child with autism. The adult playing the child with autism will wear a Bluetooth earpiece connected to a computer, which in turn will be connected to a UNMC expert. The expert will guide the actions of the adult playing the role of the child such that this confederate child will exhibit a variety of target behaviors relevant to the target skill, which will provide an opportunity for immediate feedback.
Study NCT01614275 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Technology-Enhanced Tutor Training
Description: The training for the tutors to work with children diagnosed with autism, who were assigned to the EIBI group, will complete a 40-hour structured training program for 4 to 8 weeks that includes approximately 32 sessions. When a new topic is introduced, the initial training will include viewing a PowerPoint presentation, with embedded video and audio, that explains, in laymen's terms, the basic principles and processes related to the topic. The second part of the training involves a tutor recruiting an adult friend, who will play the role of a child with autism. The adult playing the child with autism will wear a Bluetooth earpiece connected to a computer, which in turn will be connected to a UNMC expert. The expert will guide the actions of the adult playing the role of the child such that this confederate child will exhibit a variety of target behaviors relevant to the target skill, which will provide an opportunity for immediate feedback.
Study NCT01614275 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Technology-enhanced Early Intensive Behavioral Intervention
Description: After training, the ABA tutor and parents will assist in the implementation of early intervention services that will be tailored to the particular needs of the family's child. These programs could include conducting a paired-stimulus preference assessment, using a natural language program to increase spoken communication, and using matching-to-sample methods to teach categorization skills. We will record and review at least an hour of the ABA tutor's and parents' interactions with the child per week during unstructured and structured teaching situations. The purpose of these observations is to determine whether the parents are implementing the teaching strategies or behavior-management programs as designed (i.e., treatment integrity measures). If the ABA tutor or parent implements a program with less than 80% accuracy across two consecutive observations, an additional scripted role-play will be conducted as a booster session for the targeted skills.
Study NCT01614275 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: No-Intervention
Description: The ABA tutors, parents/caregivers, and children will be randomly assigned to a wait-list control group.
Study NCT03189563 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-9805 45mg
Description: DA-9805 15mg tid
Study NCT03189563 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-9805 90mg
Description: DA-9805 30mg tid
Study NCT03189563 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, tid
Study NCT02640989 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Seasonal trivalent influenza vaccine, Anflu®
Description: Seasonal trivalent influenza vaccine manufactured by Sinovac Co., Ltd.
Study NCT02640989 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Seasonal trivalent influenza vaccine, VAXIGRIP
Description: Seasonal trivalent influenza vaccine manufactured by PasteurSanofi Pasteur
Study NCT02640989 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Seasonal trivalent influenza vaccine, Fluarix
Description: Seasonal trivalent influenza vaccine manufactured by GlaxoSmithKline Biologicals
Study NCT03894267 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cutimed Siltec Heel and Sacrum dressing
Description: The dressing has been developed to facilitate exudate management in the treatment of wounds. Newly formed tissue enjoys optimal protection under a moist environment. The foam core with super-absorbers ensures reliable absorption in slightly to heavily exuding wounds. This core has an excellent retention capacity, even under compression. Hydrogen bridges bind the water so securely that, even when subject to pressure, the water is not released. Vertical absorption through the polyurethane foam and the hydro- phobic wound contact layer minimizes the risk of macerations in the peri-ulcer skin.
Study NCT03208504 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nexus™ Aortic Arch Stent graft
Description: surgical implantation of Nexus™ Aortic Arch Stent graft
Study NCT03734133 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foot insoles
Description: Different foot insoles of different hardness
Study NCT02572089 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naloxone
Study NCT03718884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirikizumab
Description: Administered SC
Study NCT02591589 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Normoxic oxygenation
Description: FiO2 set at 0.35 to maintain PaO2 > 70 mmHg or oxygen saturation greater than or equal to 92%.
Study NCT02591589 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hyperoxic oxygenation
Description: FiO2 set at 1.0 throughout the procedure
Study NCT04679675 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Subjects will receive Kaiser Permanente Washington standard of care.
Study NCT00958347 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Omnifit HA Hip Stem
Description: Total Hip Replacement with Omnifit HA Hip Stem
Study NCT00990431 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fractional carbon dioxide laser treatment
Description: The CO2 laser (Fraxel Re:pair, Solta Medical Inc., Hayward, CA) employs disposable tips with a diameter of 7 mm and 15 mm, the smaller being used for the peri-orbital region. The laser beam is delivered through multiple deflective and refractive elements and focused to a spot size of approximately 120 µm in diameter at incidence to the skin to deposit an array of laser beams across the surface. Pulse energy varies from 5 to 70 mJ and density from 5 to 70 %. The pulse duration is 10 msec. In the present study, patients received two passes at 15 mJ (1st pass) and 20 mJ (2nd pass), respectively, with a total density of 20 %.
Study NCT00990431 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fractional erbium:YAG laser treatment
Description: The Er:YAG laser used in this study has a fractional handpiece (MCL 30 Dermablate, Asclepion Laser Technologies GmbH, Jena, Germany). By means of a microlens array the laser beam is divided into 13 x 13 small spots with 250 µm diameter each, spread over an area of 13 x 13 mm. A coverage of 5 % of the skin is achieved with a single pass. The pulse duration is 400 μsec. In this trial, we performed 4 passes (resulting in coverage of 20 % of the treated skin) with a total fluence of 60 J/cm² and pulse stacking (6 stacked pulses) to optimize thermal exposure.
Study NCT01214408 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buffered pantoprazole
Description: Buffered pantoprazole 40 mg QD
Study NCT03783442 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: Administered IV
Study NCT03783442 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Administered IV
Study NCT03783442 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxaliplatin
Description: Administered IV
Study NCT03783442 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Administered IV
Study NCT03783442 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluorouracil (5-FU)
Description: Administered IV
Study NCT03783442 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluorouracil (5-FU)
Description: Administered IV
Study NCT03783442 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine
Description: Administered orally
Study NCT04679675 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Education
Description: Participants will receive an Educational Brochure describing why screening for cervical cancer is important, information about HPV and its role in cervical cancer, and different strategies for cervical cancer screening.
Study NCT02551328 — intervention group
Intervention type: DRUG
Intervention: sevofluorane
Description: Continuous infusion of sevofluorane
Study NCT04679675 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Direct Mail
Description: Participants will receive an Educational Brochure describing why screening for cervical cancer is important, information about HPV and its role in cervical cancer, and different strategies for cervical cancer screening. Participants will also receive an insert describing the home-based cervical cancer screening option and that a kit will be sent within 1 week. An HPV self-collection kit with instructions and a pre-paid return envelope (to Kaiser Permanente Washington's laboratory) will be sent to individuals with instructions on how to complete the kit.